Table 2.
Human CR1 truncation |
Cofactor activity (pM ± SD) |
|
---|---|---|
Domain | C4b | C3b |
LHR-ABC/CSL040 | 860 ± 290 | 78.9 ± 20.2 |
LHR-A | 20,460 ± 3280∗∗∗ | No activity |
LHR-AA | 16,650 ± 2700∗∗∗ | No activity |
LHR-AAA | 11,800 ± 4700∗ | Not tested |
LHR-AAAA | 14,690 ± 4220∗∗ | Not tested |
The IC50 values listed are the mean ± SD co-factor activity (in pM) of three independent experiments, shown graphically in Figure 3. Statistically significant differences for LHR-A domain variant IC50 values compared to LHR-ABC/CSL040 were calculated by an unpaired t test; ∗ p < 0.05; ∗∗ p < 0.005; and ∗∗∗ p < 0.0005.
CR1, complement receptor 1; LHR, long homologous repeat.